Structured review of federal surveillance systems and peer-reviewed evidence relevant to kratom exposure and regulatory evaluation.
Compilation of publicly available federal mortality surveillance, FDA adverse event reporting systems, poison control exposure data, regulatory communications, and scientific literature related to Mitragyna speciosa and its alkaloids.
Kratom (Mitragyna speciosa) is a plant-derived substance containing multiple bioactive alkaloids, including mitragynine and 7-hydroxymitragynine. These compounds have documented pharmacologic activity and have been evaluated in multiple surveillance and toxicologic systems.
This site consolidates publicly accessible federal data sources and peer-reviewed research to provide a structured reference for legislative and regulatory review.
Surveillance systems identify reported exposures and outcomes. They do not independently establish incidence or causation.
Federal and state systems track overdose deaths and document substances detected on postmortem toxicology. Annual CDC SUDORS reporting and related analyses are summarized in a dedicated mortality reference page.
FDA adverse event reporting systems (FAERS and CAERS) collect voluntary submissions describing health outcomes potentially associated with product exposure. Reported outcomes include hospitalization, serious medical events, and deaths.
The National Poison Data System (NPDS) compiles real-time reports from U.S. poison centers regarding kratom exposures. Data include annual call volume, single-substance exposures, pediatric involvement, healthcare facility management, and severity classifications.
An indexed collection of peer-reviewed clinical case reports organized by primary organ system. These reports describe documented medical presentations associated with kratom exposure.
FDA-registered and peer-reviewed human studies evaluating kratom and its alkaloids under controlled clinical conditions, including pharmacokinetics, metabolic formation of 7-hydroxymitragynine, dose response, and subjective drug-effect measures.
What is kratom?
Kratom refers to the plant Mitragyna speciosa, which contains alkaloids including mitragynine and 7-hydroxymitragynine with documented pharmacologic activity.
Does this site make policy recommendations?
No. This site compiles publicly available federal and scientific information for educational and legislative reference.
Do adverse event reports establish causation?
Adverse event reporting systems identify reported outcomes but do not independently determine causation without further scientific evaluation.